{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T09:52:04Z","timestamp":1720518724995},"reference-count":10,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,10]],"date-time":"2018-07-10T00:00:00Z","timestamp":1531180800000},"content-version":"vor","delay-in-days":374,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"crossref","award":["CA051497","CA057341"],"award-info":[{"award-number":["CA051497","CA057341"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009730","name":"Stand Up To Cancer","doi-asserted-by":"crossref","award":["SU2C-AACR- 395 DT0509"],"award-info":[{"award-number":["SU2C-AACR- 395 DT0509"]}],"id":[{"id":"10.13039\/100009730","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["cancercell.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Cell"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.ccell.2017.06.006","type":"journal-article","created":{"date-parts":[[2017,7,10]],"date-time":"2017-07-10T13:30:47Z","timestamp":1499693447000},"page":"3-5","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["MUC-king with HIF May Rewire Pyrimidine Biosynthesis and Curb Gemcitabine Resistance in Pancreatic Cancer"],"prefix":"10.1016","volume":"32","author":[{"given":"Chi V.","family":"Dang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccell.2017.06.006_bib1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature16965","volume":"531","author":"Bailey","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2017.06.006_bib2","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1126\/science.1228792","volume":"339","author":"Ben-Sahra","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ccell.2017.06.006_bib3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.drup.2015.10.002","volume":"23","author":"Binenbaum","year":"2015","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.ccell.2017.06.006_bib4","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1158\/1078-0432.CCR-16-2070","volume":"23","author":"Borazanci","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccell.2017.06.006_bib5","doi-asserted-by":"crossref","first-page":"5793","DOI":"10.1158\/1078-0432.CCR-11-0341","volume":"17","author":"Garrido-Laguna","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccell.2017.06.006_bib6","doi-asserted-by":"crossref","first-page":"e2722","DOI":"10.1371\/journal.pone.0002722","volume":"3","author":"Liu","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.ccell.2017.06.006_bib7","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.4161\/cc.6390","volume":"7","author":"Mannava","year":"2008","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ccell.2017.06.006_bib8","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.pan.2016.12.013","volume":"17","author":"Rajabpour","year":"2017","journal-title":"Pancreatology"},{"key":"10.1016\/j.ccell.2017.06.006_bib9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ccell.2017.06.004","volume":"32","author":"Shukla","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2017.06.006_bib10","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1158\/1535-7163.MCT-16-0050","volume":"15","author":"Wirth","year":"2016","journal-title":"Mol. Cancer Ther."}],"container-title":["Cancer Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153561081730257X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153561081730257X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T07:01:58Z","timestamp":1535612518000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S153561081730257X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S153561081730257X"],"URL":"https:\/\/doi.org\/10.1016\/j.ccell.2017.06.006","relation":{},"ISSN":["1535-6108"],"issn-type":[{"value":"1535-6108","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MUC-king with HIF May Rewire Pyrimidine Biosynthesis and Curb Gemcitabine Resistance in Pancreatic Cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccell.2017.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ccell.2017.06.004","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}